Oncology Informatics Market Size, Share & Trends Analysis Report By Types (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support Systems (CDSS), Drug Discovery and Development Informatics, and Image Analytics), End-Users, Region, And Segment Forecasts, 2023-2031.
The Oncology Informatics Market Size is valued at 6.06 Billion in 2022 and is predicted to reach 11.81 Billion by the year 2031 at a 7.9 % CAGR during the forecast period for 2023-2031.
Oncology informatics plays a vital role in cancer research and treatment. Different resources, methods, and devices/tools are used in this field to deal with cancer. Oncology informatics is very useful in the process of drug discovery and development. The oncology informatics market is growing due to an increasing number of cancer patients and the rise in the adoption of advanced technologies.
There are multiple factors that drive the oncology informatics market, such as the high prevalence of cancer, rising adoption of advanced technologies (EHRs), medical errors reduction in cancer care, the rising cost of cancer care, various government initiatives for the cancer therapy developments and increase in the awareness of the different types of oncology treatments. However, factors such as the high cost of tools, shortage of medical oncologists, data security concerns, and complex and time-consuming therapy procedures can downscale the growth of the oncology informatics market over the forecast period.
Market Segmentation
The oncology informatics market has been segmented into Types, End-users, and Regions. The Types segment comprises Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support Systems (CDSS), Drug Discovery and Development Informatics, and Image Analytics. EHR is expected to dominate the market during the forecast period. Oncology image analytics solutions are also expected to grow at the highest CAGR during the forecast period. By End-users, the market is divided into Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, and Others (Hospitals and Other Care Facilities). In terms of revenue, pharmaceutical Industries and life science industries are the major end-users segments of the oncology informatics market. At the regional level, the oncology informatics market can be segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to be the significant market shareholder of this market, followed by Asia-Pacific, Europe, and Rest-of-the-World.
Competitive Landscape
Some of The Key Players in The Oncology Informatics Market:
- Cerner Corporation
- Change Healthcare
- Elekta AB
- Hoffmann-La Roche Ltd
- Hologic, Inc.
- IBM Corporation
- Inspirata, Inc.
- Koninklijke Philips N.V.
- Laboratory Corporation of America Holdings
- McKesson Corporation
- MIM Software, Inc.
- Oncology Analytics, Inc
- PerkinElmer, Inc.
- RELX Group
- Sirenas, LLC
- UnitedHealth Group, Inc
- Varian Medical Systems, Inc
- DOSIsoft SA
- ViewRay Inc.
- Prowess, Inc.
- Flatiron Health
- RaySearch Laboratories
- Other Prominent Players
The Oncology Informatics Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 6.06 Billion |
| Revenue Forecast In 2031 | USD 11.81 Billion |
| Growth Rate CAGR | CAGR of 7.9 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Types, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Cerner Corporation, Change Healthcare, Elekta AB, F. Hoffmann-La Roche Ltd, Hologic, Inc., IBM Corporation, Inspirata, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc., Oncology Analytics, Inc, PerkinElmer, Inc., RELX Group, Sirenas, LLC, UnitedHealth Group, Inc, Varian, Medical Systems, Inc, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Oncology Informatics Market Segmentation
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Types
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- Image Analytics
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on End-users
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Oncology Informatics Market Revenue (US$ Million) By Country,
- U.S.
- Canada
Europe Oncology Informatics Market Revenue (US$ Million) By Country,
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Oncology Informatics Market Revenue (US$ Million) By Country,
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Oncology Informatics Market Revenue (US$ Million) By Country,
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Oncology Informatics Market Revenue (US$ Million) By Country,
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
The Oncology Informatics Market Size is valued at 6.06 Billion in 2022 and is predicted to reach 11.81 Billion by the year 2031..
The Oncology Informatics Market is expected to grow at a 7.9 % CAGR during the forecast period for 2023-2031.
Cerner Corporation, Change Healthcare, Elekta AB, F. Hoffmann-La Roche Ltd, Hologic, Inc., IBM Corporation, Inspirata, Inc., Koninklijke Philips N.V.,
Types and End-Users are the key segments of the Oncology Informatics Market.
North American region is leading the Oncology Informatics Market.